journal article·2026-04

Mechanistic and kinetic insights into rubiadin phototoxicity: Linking theory to photodynamic efficiency

Maciej Spiegel

Dyes and Pigments· Volume 247
Publisher page

Abstract

Phototoxic outcomes in photodynamic therapy depend sensitively on photosensitizer speciation, triplet formation pathways, and oxygen availability. Here, first-principles excited-state dynamics was combined with kinetic modelling to dissect the photochemistry of the plant anthraquinone rubiadin. Ground- and excited-state calculations reveal that the neutral species undergoes barrierless excited state intramolecular proton transfer that channels population into a long-lived triplet reservoir with high ΦT, whereas the monoanion relaxes almost exclusively by internal conversion, quenching phototoxicity. Two-photon cross-sections are intrinsically small, consistent with the asymmetric substitution pattern. Triplet–triplet Dexter transfer to O₂ is exergonic and efficient, while radical-mediated type I/III pathways are hindered by large reorganization energies. These photophysical insights underlie the pH-dependent ΦΔ, with a sharp inflection near the H₂Rbd/HRbd⁻ crossover. Parameterized ordinary differential equation models further quantify how photosensitizer loading, initial oxygen concentration, and oxygen resupply rates control the competition between productive Dexter transfer and nonproductive decay pathways, predicting steep losses in ¹O₂ yield under hypoxic conditions. Collectively, this work highlights the interplay of molecular speciation, triplet dynamics, and oxygen kinetics in governing PDT efficiency and informs strategies for mitigating hypoxia-limited phototoxicity.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Photodynamic Therapy Research Studies · Photochemistry and Electron Transfer Studies · Skin Protection and Aging

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (88)

Show source-provided references
1. Unveiling the mechanisms and challenges of cancer drug resistance10.1186/s12964-023-01302-1 ↗
2. The complexity and regulation of repair of alkylation damage to nucleic acids10.1080/10409238.2020.1869173 ↗
3. Unveiling the role of O(6)–methylguanine–DNA methyltransferase in cancer therapy: insights into alkylators, pharmacogenomics, and others
4. Dihydropyrimidine dehydrogenase–mediated resistance to 5–Fluorouracil: mechanistic investigation and solution10.1021/acsptsci.2c00117 ↗
5. A new technique for the analysis of metabolic pathways of cytidine analogues and cytidine deaminase activities in cells10.1038/s41598-023-47792-4 ↗
6. The association of ABC proteins with multidrug resistance in cancer10.1016/j.bbamcr.2024.119878 ↗
7. Photodynamic therapy (PDT): PDT mechanisms10.5946/ce.2013.46.1.24 ↗
8. The concept and examples of type–III photosensitisers for cancer photodynamic therapy10.1016/j.chempr.2021.10.006 ↗
9. New designs for phototherapeutic transition metal complexes10.1002/anie.201905171 ↗
10. Transition metal complexes and photodynamic therapy from a tumor–centered approach: challenges, opportunities, and highlights from the development of TLD143310.1021/acs.chemrev.8b00211 ↗
11. Triplet state. Its radiative and nonradiative properties10.1021/ar50001a002 ↗
12. Metal–based photosensitisers as inducers of regulated cell death mechanisms10.1021/acs.chemrev.3c00161 ↗
13. Photodynamic therapy for cancer: role of natural products10.1016/j.pdpdt.2019.04.033 ↗
14. Cytotoxic and antitumor agents from genus Rubia10.1002/cbdv.202401498 ↗
15. Chemistry, biosynthesis, physicochemical and biological properties of rubiadin: a promising natural anthraquinone for new drug discovery and development10.2147/DDDT.S338548 ↗
16. Photochemotherapy using natural anthraquinones: Rubiadin and Soranjidiol sensitize human cancer cell to die by apoptosis10.1016/j.pdpdt.2014.02.002 ↗
17. Hypericin and its anticancer effects: from mechanism of action to potential therapeutic application10.1016/j.phymed.2022.154356 ↗
18. Photoactivity of hypericin: from natural product to antifungal application10.1080/1040841X.2022.2036100 ↗
19. Antimicrobial efficacy of aloe–emodin mediated photodynamic therapy against antibiotic–resistant Pseudomonas aeruginosa in vitro10.1016/j.bbrc.2023.149285 ↗
20. On the photosensitizing properties of aloe–emodin in photodynamic therapy: insights from the molecular modeling10.1021/acs.jpcb.5c01117 ↗
21. Photodynamic inactivation of Staphylococcus aureus using aloe–emodin as photosensitiser10.1016/j.foodres.2024.113959 ↗
22. Soranjidiol as a photosensitiser: mechanistic insights into its photochemistry and photoinduced tautomerization10.1016/j.jphotobiol.2025.113203 ↗
23. Natural photosensitisers in photodynamic therapy: in vitro activity against monolayers and spheroids of human colorectal adenocarcinoma SW480 cells10.1016/j.pdpdt.2020.101852 ↗
24. A promising natural anthraquinones mediated by photodynamic therapy for anti–cancer therapy10.1016/j.phymed.2023.155035 ↗
25. Some natural photosensitisers and their medicinal properties for use in photodynamic therapy10.3390/molecules27041192 ↗
26. Plants–occurring anthraquinones as photosensitive compounds for photodynamic method: a critical overview10.31083/j.fbl2905168 ↗
27. An overview of potential natural photosensitisers in cancer photodynamic therapy10.3390/biomedicines11010224 ↗
28. Anthraquinone–centered type I photosensitiser with aggregation–induced emission characteristics for tumor–targeted two–photon photodynamic therapy10.1021/acsmaterialslett.4c00600 ↗
29. Effect of substituents on the photodynamic action of anthraquinones: EPR, computational and in vitro studies10.1111/php.13617 ↗
30. The photoactivity of natural products – an overlooked potential of phytomedicines?10.1016/j.phymed.2019.152985 ↗
31. Design and optimization of triplet–triplet annihilation upconversion annihilators10.1016/j.trechm.2025.02.002 ↗
32. Triplet formation and triplet‐triplet annihilation upconversion in iodine substituted non‐orthogonal BODIPY‐Perylene dyads10.1002/cptc.202300073 ↗
33. Singlet fission driven by excited‐state intramolecular proton transfer (ESIPT+SF): a (TD)DFT study10.1002/cptc.202300017 ↗
34. Understanding the mechanism of triplet‐triplet energy transfer in the photocatalytic [2 + 2] cycloaddition: insights from quantum chemical modeling10.1002/jcc.70155 ↗
35. GOAT: a global optimization algorithm for molecules and atomic clusters10.1002/anie.202500393 ↗
36. Software update: the ORCA program system—Version 5.010.1002/wcms.1606 ↗
37. The ORCA quantum chemistry program package10.1063/5.0004608 ↗
38. GFN2–xTB—An accurate and broadly parametrized self–consistent tight–binding quantum chemical method with multipole electrostatics and density–dependent dispersion contributions10.1021/acs.jctc.8b01176 ↗
39. Fast domain decomposition algorithm for continuum solvation models: energy and first derivatives10.1021/ct400280b ↗
40. Polarizable molecular dynamics in a polarizable continuum solvent10.1021/ct500998q ↗
41. Spiegel
42. Balanced basis sets of split valence, triple zeta valence and quadruple zeta valence quality for H to Rn: design and assessment of accuracy10.1039/b508541a ↗
43. Climbing the density functional ladder: nonempirical meta–generalized gradient approximation designed for molecules and solids10.1103/PhysRevLett.91.146401 ↗
44. Comparative assessment of a new nonempirical density functional: molecules and hydrogen–bonded complexes10.1063/1.1626543 ↗
45. A generally applicable atomic–charge dependent London dispersion correction10.1063/1.5090222 ↗
46. Universal solvation model based on solute electron density and on a continuum model of the solvent defined by the bulk dielectric constant and atomic surface tensions10.1021/jp810292n ↗
47. Estimation of empirically fitted parameters for calculating pK a values of thiols in a fast and reliable way10.1007/s00214-017-2179-7 ↗
48. Empirically fitted parameters for calculating pKa values with small deviations from experiments using a simple computational strategy10.1021/acs.jcim.6b00310 ↗
49. Frisch · 2016
50. Time–dependent density functional theory within the tamm–Dancoff approximation10.1016/S0009-2614(99)01149-5 ↗
51. The importance of the electron spectrum in multi atomic molecules. Concerning the Franck–Condon principle
52. Electron transfer reactions in chemistry. Theory and experiment10.1103/RevModPhys.65.599 ↗
53. Chemical and electrochemical electron–transfer theory10.1146/annurev.pc.15.100164.001103 ↗
54. Electron transfers in chemistry and biology10.1016/0304-4173(85)90014-X ↗
55. On the theory of oxidation–reduction reactions involving electron transfer. II. Applications to data on the rates of isotopic exchange reactions10.1063/1.1743423 ↗
56. Software for the frontiers of quantum chemistry: an overview of developments in the Q–Chem 5 package10.1063/5.0055522 ↗
57. Theory and calculation for the electronic coupling in excitation energy transfer10.1002/qua.24528 ↗
58. The Dalton quantum chemistry program system10.1002/wcms.1172 ↗
59. Gaussian basis sets for use in correlated molecular calculations. I. The atoms boron through neon and hydrogen10.1063/1.456153 ↗
60. Development of the Colle–Salvetti correlation–energy formula into a functional of the electron density10.1103/PhysRevB.37.785 ↗
61. Density–functional thermochemistry. III. The role of exact exchange10.1063/1.464913 ↗
62. Quantum mechanical continuum solvation models10.1021/cr9904009 ↗
63. Benchmarking two–photon absorption cross sections: performance of CC2 and CAM–B3LYP10.1039/C5CP03241E ↗
64. Degenerate and non–degenerate two–photon absorption of coumarin dyes10.1039/D3CP00723E ↗
65. Natural anthraquinones probed as type I and type II photosensitisers: singlet oxygen and superoxide anion production10.1016/j.jphotobiol.2004.09.009 ↗
66. On the mechanism of Candida tropicalis biofilm reduction by the combined action of naturally–occurring anthraquinones and blue light10.1371/journal.pone.0181517 ↗
67. Two–photon photodynamic therapy with curcumin nanocomposite10.1016/j.colsurfb.2024.114306 ↗
68. Two–photon excitation photosensitisers for photodynamic therapy: from small–molecules to nano–complex systems10.1016/j.ccr.2024.215711 ↗
69. Two–photon absorption: an open door to the NIR–II biological window?10.3389/fchem.2022.921354 ↗
70. Proton pachinko: probing excited‐state intramolecular proton transfer of St. John's wort‐derived fluorescent photosensitiser hypericin with ultrafast spectroscopy∗∗
71. Modern theoretical approaches to modeling the excited–state intramolecular proton transfer: an overview10.3390/molecules26175140 ↗
72. Investigation of a series of 2–(2′–Hydroxyaryl)benzazole derivatives: photophysical properties, excited–state intramolecular proton–transfer reactions, and observation of long–lived triplet excited states10.1021/acs.jpcb.1c05798 ↗
73. Internal conversion of singlet and triplet states employing numerical DFT/MRCI derivative couplings: implementation, tests, and application to xanthone10.1063/5.0056182 ↗
74. Rapid calculation of internal conversion and intersystem crossing rate for organic materials discovery10.1063/5.0102857 ↗
75. Fast calculation of internal conversion rate constant using the time–dependent formalism10.1016/j.cplett.2024.141147 ↗
76. An energy–gap correlation of internal conversion rates10.1016/0009-2614(79)80489-3 ↗
77. Photophysical properties of a chiral iridium–based photosensitiser as an efficient photodynamic therapy agent: a theoretical investigation10.3390/ijms26115062 ↗
78. Understanding the photophysical properties of Pd and Pt transition‐metal isocorroles: a theoretical investigation10.1002/chem.202403725 ↗
79. Formation of genotoxic metabolites from anthraquinone glycosides, present in Rubia tinctorum L
80. Studies of interaction of emodin and DNA in the presence of ethidium bromide by spectroscopic method10.1016/j.saa.2007.03.017 ↗
81. Peebles · Biochem Pharmacol · 2001 · 62 · 105910.1016/S0006-2952(01)00759-6 ↗
82. Isolation and cytotoxic effect of anthraquinones from Morinda umbellata10.1055/s-0034-1382956 ↗
83. Biological activity of anthraquinones and triterpenoids from Prismatomeris fragrans10.1016/j.jep.2005.03.018 ↗
84. Carcinogenic potential of alizarin and rubiadin, components of madder color, in a rat medium‐term multi‐organ bioassay10.1111/j.1349-7006.2009.01342.x ↗
85. Dysregulated pH: a perfect storm for cancer progression10.1038/nrc3110 ↗
86. Why do cancers have high aerobic glycolysis?10.1038/nrc1478 ↗
87. pH sensing and regulation in cancer10.3389/fphys.2013.00370 ↗
88. Macroscopic modeling of the singlet oxygen production during PDT